Digital divide for COVID-19 vaccines persists, even as supplies increase
KTRK
Share:
HOUSTON, Texas (KTRK) As COVID-19 vaccines continue to roll into Texas, there are growing concerns that access to the coveted shots are often dependent on how digitally connected people are. The better connect, the better chances of getting a vaccine.
On Tuesday, Gov. Greg Abbott highlighted the positive aspects of the vaccine rollout so far in a roundtable discussion at Houston Methodist Hospital. He pointed to the fact that more than 1.3 million doses have so far been given to Texans, and the state is set to distribute this week its largest shipment to date.
Covishield: Manufacturer, dose schedule, efficacy rate, possible side effects and price
India
Updated: Saturday, January 16, 2021, 15:26 [IST]
New Delhi, Jan 16: Covishield vaccine has been developed by the University of Oxford and British-Swedish pharmaceutical company AstraZeneca.
Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII) which is British-Swedish pharma giant AstraZeneca s manufacturing partner - said that the vaccine would be 90 to 95 per cent effective if the two shots are parted by around 2-3 months.
File Photo
The vaccine is being touted as one of the most promising vaccines for India where cost and logistics play a big roll. You ll be hearing some good news from the UK very soon. It would be a 90-95 per cent effective vaccine if you just keep a two-to-three months gap between dose 1 and dose 2. They will make that public with documentation.
What does the consent form that must be signed by Covaxin recipients say?
India
Published: Saturday, January 16, 2021, 15:29 [IST]
New Delhi, Jan 16: The consent form that must be signed by Covaxin beneficiaries states that its efficacy is yet to be established. It assures compensation by Bharat Biotech in case of a serious adverse event that is proven to be causally related to the vaccine. It further states that beneficiaries would be provided care in government-designated facilities if they suffer any adverse events.
The form read that only phase 1 and 2 trials have been completed, and that phase 3 is still on.
Representational Image
Meet Manish Kumar, India’s first Covid vaccine recipient
India
Published: Saturday, January 16, 2021, 16:31 [IST]
New Delhi, Jan 16: Manish Kumar, a 34-year-old machine operator at AIIMS became the first person in Delhi to get the COVID-19 vaccine. He had himself asked the hospital authorities to be vaccinated first as his colleagues chosen for the exercise were scared to get the jab.
First Indian gets vaccinated | Witness the historic moment | Oneindia News
Kumar, whose mother Laxmi Rani also works at the hospital, said he was not at all nervous, had a good sleep and was proud of getting the vaccine .
He was administered a COVID-19 vaccine during the launch of the nationwide vaccination programme at the All India Institute of Medical Sciences in the presence of Union Health Minister Harsh Vardhan on Saturday.